nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—SLC22A8—choroid plexus—intracranial aneurysm	0.291	0.471	CbGeAlD
Ketoprofen—CXCL8—medulla oblongata—intracranial aneurysm	0.0344	0.0556	CbGeAlD
Ketoprofen—PTGS1—artery—intracranial aneurysm	0.0321	0.052	CbGeAlD
Ketoprofen—CXCL8—midbrain—intracranial aneurysm	0.0314	0.0509	CbGeAlD
Ketoprofen—PTGS2—artery—intracranial aneurysm	0.0307	0.0497	CbGeAlD
Ketoprofen—CXCL8—cerebellum—intracranial aneurysm	0.0243	0.0393	CbGeAlD
Ketoprofen—CXCR1—Peptide GPCRs—EDNRA—intracranial aneurysm	0.0226	0.0591	CbGpPWpGaD
Ketoprofen—CXCL8—brain—intracranial aneurysm	0.0197	0.032	CbGeAlD
Ketoprofen—CXCR1—GPCRs, Other—EDNRA—intracranial aneurysm	0.0191	0.0501	CbGpPWpGaD
Ketoprofen—SLCO1A2—medulla oblongata—intracranial aneurysm	0.0168	0.0272	CbGeAlD
Ketoprofen—SLC22A7—brain—intracranial aneurysm	0.016	0.0258	CbGeAlD
Ketoprofen—SLC22A6—brain—intracranial aneurysm	0.0154	0.0249	CbGeAlD
Ketoprofen—SLCO1A2—midbrain—intracranial aneurysm	0.0154	0.0249	CbGeAlD
Ketoprofen—CXCR1—Chemokine receptors bind chemokines—CCL2—intracranial aneurysm	0.0139	0.0364	CbGpPWpGaD
Ketoprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0125	0.0326	CbGpPWpGaD
Ketoprofen—CXCL8—ATF4 activates genes—CCL2—intracranial aneurysm	0.012	0.0313	CbGpPWpGaD
Ketoprofen—SLCO1A2—cerebellum—intracranial aneurysm	0.0119	0.0193	CbGeAlD
Ketoprofen—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.0116	0.0303	CbGpPWpGaD
Ketoprofen—CXCL8—PERK regulates gene expression—CCL2—intracranial aneurysm	0.0109	0.0286	CbGpPWpGaD
Ketoprofen—CXCR1—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.0106	0.0278	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—TIMP1—intracranial aneurysm	0.0104	0.0272	CbGpPWpGaD
Ketoprofen—SLCO1A2—brain—intracranial aneurysm	0.00967	0.0156	CbGeAlD
Ketoprofen—ALB—brain—intracranial aneurysm	0.00961	0.0156	CbGeAlD
Ketoprofen—ABCC4—brain—intracranial aneurysm	0.0093	0.0151	CbGeAlD
Ketoprofen—SLC22A8—brain—intracranial aneurysm	0.00923	0.0149	CbGeAlD
Ketoprofen—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.0092	0.0241	CbGpPWpGaD
Ketoprofen—PTGS2—medulla oblongata—intracranial aneurysm	0.00912	0.0148	CbGeAlD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—intracranial aneurysm	0.00875	0.0229	CbGpPWpGaD
Ketoprofen—CXCL8—Syndecan-2-mediated signaling events—MMP2—intracranial aneurysm	0.00851	0.0223	CbGpPWpGaD
Ketoprofen—PTGS2—midbrain—intracranial aneurysm	0.00833	0.0135	CbGeAlD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—intracranial aneurysm	0.00832	0.0218	CbGpPWpGaD
Ketoprofen—CXCR1—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00832	0.0218	CbGpPWpGaD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—intracranial aneurysm	0.0078	0.0204	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—STARD13—intracranial aneurysm	0.00754	0.0197	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet degranulation—TIMP1—intracranial aneurysm	0.00731	0.0191	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00713	0.0187	CbGpPWpGaD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00696	0.0182	CbGpPWpGaD
Ketoprofen—CYP2C8—brain—intracranial aneurysm	0.00676	0.0109	CbGeAlD
Ketoprofen—PTGS2—cerebellum—intracranial aneurysm	0.00645	0.0104	CbGeAlD
Ketoprofen—CXCL8—Chemokine receptors bind chemokines—CCL2—intracranial aneurysm	0.00628	0.0164	CbGpPWpGaD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—intracranial aneurysm	0.00625	0.0164	CbGpPWpGaD
Ketoprofen—CXCL8—ATF-2 transcription factor network—MMP2—intracranial aneurysm	0.00573	0.015	CbGpPWpGaD
Ketoprofen—PTGS1—brain—intracranial aneurysm	0.00548	0.00886	CbGeAlD
Ketoprofen—CXCR1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00543	0.0142	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—MMP2—intracranial aneurysm	0.00537	0.0141	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—CCL2—intracranial aneurysm	0.00525	0.0137	CbGpPWpGaD
Ketoprofen—PTGS2—brain—intracranial aneurysm	0.00524	0.00847	CbGeAlD
Ketoprofen—CXCR1—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00523	0.0137	CbGpPWpGaD
Ketoprofen—CXCL8—Unfolded Protein Response (UPR)—CCL2—intracranial aneurysm	0.00482	0.0126	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00479	0.0126	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—intracranial aneurysm	0.00449	0.0118	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—MMP9—intracranial aneurysm	0.00403	0.0106	CbGpPWpGaD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—NOS3—intracranial aneurysm	0.00376	0.00985	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—MMP9—intracranial aneurysm	0.00376	0.00983	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00351	0.00919	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—CCL2—intracranial aneurysm	0.00346	0.00905	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—STARD13—intracranial aneurysm	0.0034	0.00891	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—intracranial aneurysm	0.00337	0.00884	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—TIMP1—intracranial aneurysm	0.00331	0.00866	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00324	0.00849	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00322	0.00842	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—AGER—intracranial aneurysm	0.00319	0.00834	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00315	0.00825	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00307	0.00803	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00304	0.00797	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00278	0.00729	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—CCL2—intracranial aneurysm	0.00267	0.007	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00255	0.00667	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00247	0.00647	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00245	0.00641	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00241	0.00632	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—CCL2—intracranial aneurysm	0.0024	0.00628	CbGpPWpGaD
Ketoprofen—ABCC4—Ectoderm Differentiation—CCL2—intracranial aneurysm	0.00239	0.00626	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00236	0.00619	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00232	0.00606	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—SLC25A16—intracranial aneurysm	0.00205	0.00536	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—CCL2—intracranial aneurysm	0.00195	0.00511	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00192	0.00502	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00184	0.00481	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NCF1—intracranial aneurysm	0.00174	0.00456	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TIMP1—intracranial aneurysm	0.00167	0.00438	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00164	0.00431	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00158	0.00415	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SLC25A16—intracranial aneurysm	0.00156	0.00408	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00155	0.00406	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—CCL2—intracranial aneurysm	0.00151	0.00397	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.0015	0.00392	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00149	0.00389	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SLC25A16—intracranial aneurysm	0.00148	0.00386	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00147	0.00384	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00138	0.00362	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—CCL2—intracranial aneurysm	0.00137	0.00359	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ASAH1—intracranial aneurysm	0.00136	0.00355	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00126	0.00329	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC25A16—intracranial aneurysm	0.00124	0.00324	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00122	0.00319	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—CCL2—intracranial aneurysm	0.00121	0.00316	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00108	0.00284	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ASAH1—intracranial aneurysm	0.00103	0.0027	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC25A16—intracranial aneurysm	0.00101	0.00263	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC25A16—intracranial aneurysm	0.001	0.00262	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—CCL2—intracranial aneurysm	0.000849	0.00222	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ASAH1—intracranial aneurysm	0.000819	0.00214	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC25A16—intracranial aneurysm	0.000818	0.00214	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCL2—intracranial aneurysm	0.000811	0.00212	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—MMP2—intracranial aneurysm	0.000808	0.00211	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NCF1—intracranial aneurysm	0.000786	0.00206	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TIMP1—intracranial aneurysm	0.000756	0.00198	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—NOS3—intracranial aneurysm	0.000753	0.00197	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EDNRA—intracranial aneurysm	0.000742	0.00194	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NOS3—intracranial aneurysm	0.000722	0.00189	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ASAH1—intracranial aneurysm	0.000666	0.00174	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ASAH1—intracranial aneurysm	0.000662	0.00173	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CCL2—intracranial aneurysm	0.000619	0.00162	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MMP9—intracranial aneurysm	0.00058	0.00152	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CST3—intracranial aneurysm	0.000566	0.00148	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ASAH1—intracranial aneurysm	0.000542	0.00142	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NCF1—intracranial aneurysm	0.000492	0.00129	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCL2—intracranial aneurysm	0.000366	0.000958	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NOS3—intracranial aneurysm	0.000341	0.000892	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NOS3—intracranial aneurysm	0.000326	0.000854	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—NOS3—intracranial aneurysm	0.000283	0.000741	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—intracranial aneurysm	0.000262	0.000685	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NOS3—intracranial aneurysm	0.000215	0.000563	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOS3—intracranial aneurysm	0.000204	0.000534	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NOS3—intracranial aneurysm	0.000171	0.000447	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NOS3—intracranial aneurysm	0.000139	0.000364	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NOS3—intracranial aneurysm	0.000138	0.000362	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NOS3—intracranial aneurysm	0.000113	0.000296	CbGpPWpGaD
